BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12007187)

  • 21. Telomerase activation and human papillomavirus infection in invasive uterine cervical carcinoma in a set of Malaysian patients.
    Cheah PL; Looi LM; Ng MH; Sivanesaratnam V
    J Clin Pathol; 2002 Jan; 55(1):22-6. PubMed ID: 11825919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancer.
    Widschwendter A; Müller HM; Hubalek MM; Wiedemair A; Fiegl H; Goebel G; Mueller-Holzner E; Marth C; Widschwendter M
    Gynecol Oncol; 2004 May; 93(2):407-16. PubMed ID: 15099954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human telomerase gene amplification and high-risk human papillomavirus infection in women with cervical intra-epithelial neoplasia.
    Takac I; Arko D; Kodric T; Poljak M; Zagorac A; Erjavec-Skerget A; Kokalj-Vokac N
    J Int Med Res; 2009; 37(5):1588-95. PubMed ID: 19930867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human papillomavirus multiplex ligation-dependent probe amplification assay for the assessment of viral load, integration, and gain of telomerase-related genes in cervical malignancies.
    Theelen W; Litjens RJ; Vinokurova S; Haesevoets A; Reijans M; Simons G; Smedts F; Herrington CS; Ramaekers FC; von Knebel Doeberitz M; Speel EJ; Hopman AH
    Hum Pathol; 2013 Nov; 44(11):2410-8. PubMed ID: 23968641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Telomerase level versus spliced hTERT-specific RNA forms in cervical carcinoma].
    Fedorova MD; Petrenko AA; Skvortsov DA; Pavlova LS; Zvereva ME; Rubtsova MP; Dontsova OA; Kiselev FL
    Vopr Onkol; 2010; 56(1):29-35. PubMed ID: 20361612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telomerase reverse transcriptase gene amplification in hepatocellular carcinoma.
    Takuma Y; Nouso K; Kobayashi Y; Nakamura S; Tanaka H; Matsumoto E; Fujikawa T; Suzuki M; Hanafusa T; Shiratori Y
    J Gastroenterol Hepatol; 2004 Nov; 19(11):1300-4. PubMed ID: 15482538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer.
    Hopman AH; Theelen W; Hommelberg PP; Kamps MA; Herrington CS; Morrison LE; Speel EJ; Smedts F; Ramaekers FC
    J Pathol; 2006 Dec; 210(4):412-9. PubMed ID: 17054308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [hTERC gene amplification and expression of human papillomavirus in cervical carcinogenesis].
    Li SH; Liu LL; Ma HX; Wang QH; Bai W
    Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):121-2. PubMed ID: 22455890
    [No Abstract]   [Full Text] [Related]  

  • 29. Telomerase suppression by chromosome 6 in a human papillomavirus type 16-immortalized keratinocyte cell line and in a cervical cancer cell line.
    Steenbergen RD; Kramer D; Meijer CJ; Walboomers JM; Trott DA; Cuthbert AP; Newbold RF; Overkamp WJ; Zdzienicka MZ; Snijders PJ
    J Natl Cancer Inst; 2001 Jun; 93(11):865-72. PubMed ID: 11390536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53 status and human papillomavirus infection in Thai women with cervical carcinoma.
    Limpaiboon T; Pooart J; Bhattarakosol P; Niruthisard S; Chantratita W; Lulitanond V
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):66-71. PubMed ID: 11023067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells.
    Jeong Seo E; Jung Kim H; Jae Lee C; Tae Kang H; Seong Hwang E
    Gynecol Oncol; 2004 Jul; 94(1):40-7. PubMed ID: 15262117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers.
    Ferber MJ; Montoya DP; Yu C; Aderca I; McGee A; Thorland EC; Nagorney DM; Gostout BS; Burgart LJ; Boix L; Bruix J; McMahon BJ; Cheung TH; Chung TK; Wong YF; Smith DI; Roberts LR
    Oncogene; 2003 Jun; 22(24):3813-20. PubMed ID: 12802289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can Genomic Amplification of Human Telomerase Gene and C-MYC in Liquid-Based Cytological Specimens Be Used as a Method for Opportunistic Cervical Cancer Screening?
    Gao K; Eurasian M; Zhang J; Wei Y; Zheng Q; Ye H; Li L
    Gynecol Obstet Invest; 2015; 80(3):153-63. PubMed ID: 25832290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression of human telomerase reverse transcriptase in cervix cancer and its significance].
    Xi L; Zhu T; Wu P; Xu Q; Huang L; Li KZ; Lu YP; Ma D
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jun; 40(6):407-10. PubMed ID: 16008894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer.
    Kailash U; Soundararajan CC; Lakshmy R; Arora R; Vivekanandhan S; Das BC
    Br J Cancer; 2006 Nov; 95(9):1250-7. PubMed ID: 17060942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of genomic amplification of the human telomerase gene TERC, a potential marker for triage of women with HPV-positive, abnormal Pap smears.
    Andersson S; Sowjanya P; Wangsa D; Hjerpe A; Johansson B; Auer G; Gravitt PE; Larsson C; Wallin KL; Ried T; Heselmeyer-Haddad K
    Am J Pathol; 2009 Nov; 175(5):1831-47. PubMed ID: 19880826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of telomerase by seminal plasma in malignant and normal cervical epithelial cells.
    Liu L; Liu C; Lou F; Zhang G; Wang X; Fan Y; Yan K; Wang K; Xu Z; Hu S; Björkholm M; Xu D
    J Pathol; 2011 Oct; 225(2):203-11. PubMed ID: 21590772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. hTERT Protein Expression in Cytoplasm and Nucleus and its Association With HPV Infection in Patients With Cervical Cancer.
    Moreno-Acosta P; Molano M; Morales N; Acosta J; GonzÁlez-Prieto C; Mayorga D; Buitrago L; Gamboa O; MejÍa JC; Castro J; Romero-Rojas A; Espenel S; Murray GL; Garland SM; Vallard A; MagnÉ N
    Cancer Genomics Proteomics; 2020; 17(5):615-625. PubMed ID: 32859640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of hTERT and HPV E6/E7 mRNA RT-qPCR TaqMan assays in combination for diagnosing high-grade cervical lesions and malignant tumors.
    Wang HY; Park S; Kim S; Lee D; Kim G; Kim Y; Park KH; Lee H
    Am J Clin Pathol; 2015 Mar; 143(3):344-51. PubMed ID: 25696792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Telomerase activity and expression of its RNA component in cervical lesions.
    Yashima K; Ashfaq R; Nowak J; Von Gruenigen V; Milchgrub S; Rathi A; Albores-Saavedra J; Shay JW; Gazdar AF
    Cancer; 1998 Apr; 82(7):1319-27. PubMed ID: 9529024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.